PBE
PBE
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 5.91% | 106.61K | $15.33M |
 AMGN | Amgen Inc. | 5.89% | 39.95K | $15.15M |
 BIIB | Biogen Inc. | 5.48% | 75.53K | $14.20M |
 UTHR | United Therapeutics Corporation | 5.44% | 27.98K | $14.09M |
 REGN | Regeneron Pharmaceuticals, Inc. | 5.22% | 17.54K | $13.52M |
 ILMN | Illumina, Inc. | 5.21% | 106.02K | $13.51M |
 INCY | Incyte Corporation | 4.86% | 125.70K | $12.58M |
 FOLD | Amicus Therapeutics, Inc. | 4.07% | 736.53K | $10.55M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.93% | 30.75K | $10.19M |
 BCRX | BioCryst Pharmaceuticals, Inc. | 3.25% | 1.07M | $8.43M |
 RPRX | Royalty Pharma plc | 3.22% | 183.25K | $8.31M |
 BMRN | BioMarin Pharmaceutical Inc. | 3.10% | 131.25K | $8.02M |
 CPRX | Catalyst Pharmaceuticals, Inc. | 2.97% | 309.84K | $7.71M |
 EXEL | Exelixis, Inc. | 2.95% | 172.41K | $7.63M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.90% | 304.78K | $7.51M |
 IONS | Ionis Pharmaceuticals, Inc. | 2.89% | 92.77K | $7.48M |
 PTGX | Protagonist Therapeutics, Inc. | 2.83% | 83.07K | $7.34M |
 COLL | Collegium Pharmaceutical, Inc. | 2.73% | 159.83K | $7.07M |
 VCEL | Vericel Corporation | 2.72% | 187.35K | $7.06M |
 TGTX | TG Therapeutics, Inc. | 2.71% | 227.42K | $7.03M |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
NetherlandsSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States NetherlandsHoldings (Top 20)
GILD
Gilead Sciences, Inc.
AMGN
Amgen Inc.
BIIB
Biogen Inc.
UTHR
United Therapeutics Corporation
REGN
Regeneron Pharmaceuticals, Inc.
ILMN
Illumina, Inc.
INCY
Incyte Corporation
FOLD
Amicus Therapeutics, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
BCRX
BioCryst Pharmaceuticals, Inc.
RPRX
Royalty Pharma plc
BMRN
BioMarin Pharmaceutical Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
EXEL
Exelixis, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
IONS
Ionis Pharmaceuticals, Inc.
PTGX
Protagonist Therapeutics, Inc.
COLL
Collegium Pharmaceutical, Inc.
VCEL
Vericel Corporation
TGTX
TG Therapeutics, Inc.